Juan Franco 🏳️‍🌈's Avatar

Juan Franco 🏳️‍🌈

@drjuanfranco.bsky.social

Family Physician 🇦🇷, Editor-in-Chief BMJ EBM, Lead Cochrane ESU Düsseldorf @hhu.de 🇩🇪, Editor @bmj.com. ❤️EBM/SDM/Primary Care. Personal posts. Repost ≠ endorsement.

191 Followers  |  14 Following  |  6 Posts  |  Joined: 27.11.2024  |  1.6003

Latest posts by drjuanfranco.bsky.social on Bluesky

Post image

Beyond body mass index: rethinking doctors’ advice for weight loss. Doctors should provide quality, evidence based care reflecting individual preferences and needs, regardless of weight, write @drjuanfranco.bsky.social ‪ @emmagram.bsky.social & colleagues #BMI
@bmj.com www.bmj.com/content/389/...

27.06.2025 07:47 — 👍 1    🔁 2    💬 0    📌 0
Bias word

Bias word

A new tool helps to assess the risk of bias in network meta-analysis of healthcare interventions.

Read the guidance article
www.bmj.com/content/388/...

19.03.2025 21:09 — 👍 26    🔁 9    💬 0    📌 0
Preview
Improving peer review of systematic reviews and related review types by involving librarians and information specialists as methodological peer reviewers: a randomised controlled trial Objective To evaluate the impact of adding librarians and information specialists (LIS) as methodological peer reviewers to the formal journal peer review process on the quality of search reporting an...

Improving peer review of systematic reviews and related review types by involving librarians and information specialists as methodological peer reviewers: a randomised controlled trial

18.03.2025 06:40 — 👍 17    🔁 7    💬 1    📌 2
Preview
Wissenschaftlicher Mitarbeiter - Qualitative Forschung (m/w/d) Aktuelles Stellenangebot als Wissenschaftlicher Mitarbeiter bei der Firma Universitätsklinikum Düsseldorf in Düsseldorf

Wir habe eine interessante Stelle ausgeschrieben für eine*n Wissenschaftliche*n Mitarbeiter*in qualitative Forschung für unser neues EKOCAN Projekt zur Evaluation des Konsumcannabisgesetzes! Jetzt bewerben: www.jobvector.de/jobs/ekocan/...

11.03.2025 09:31 — 👍 2    🔁 3    💬 0    📌 0
Post image

Dr. Brenda Bongaerts @hhu.de und @drjuanfranco.bsky.social zu Senior Editoren der Cochrane Database of Systematic Reviews ernannt!🎉
Ihr Engagement bei #Cochrane trägt dazu bei, unabhängige und verlässliche Evidenz für die globale Gesundheitsversorgung bereitzustellen.

Mehr Infos: shorturl.at/jMaqA

11.03.2025 15:26 — 👍 4    🔁 3    💬 0    📌 0
Post image

New #TalkEvidence podcast with Helen and me, this time focusing on hospitals - asking how useful UTI dipstick tests really are for acutely ill patients, and what are the effects of staff turnover on patient care in NHS hospitals?

🎧 Apple Podcasts: apple.co/4hH5jA0

🎧 Spotify: spoti.fi/3X7xksl

20.02.2025 10:45 — 👍 1    🔁 0    💬 0    📌 0

Thank you for being part of the BMJ EBM Community! Re Bluesky, working on it!

01.02.2025 10:04 — 👍 2    🔁 1    💬 0    📌 0
Editorial on drugs for obesity. 

Excerpt here:

The need for lifelong support has implications for individuals and public health

More than a billion people worldwide are living with obesity. After many years of failed attempts to support them in losing weight and optimising their health through lifestyle intervention programmes, glucagon-like peptide-1 (GLP-1) receptor agonists are being heralded as a magic bullet for this global problem.

Public discourse on these drugs has focused on their off-label use by celebrities, their exorbitant pricing, and severe supply shortages. But these issues are distractions from difficult questions about the long term implications of using these drugs in holistic obesity care systems, for both individual patients and for public health—namely, for whom, for what purpose, and how should these drugs be used when taking a lifecourse view of care for people with obesity?

Editorial on drugs for obesity. Excerpt here: The need for lifelong support has implications for individuals and public health More than a billion people worldwide are living with obesity. After many years of failed attempts to support them in losing weight and optimising their health through lifestyle intervention programmes, glucagon-like peptide-1 (GLP-1) receptor agonists are being heralded as a magic bullet for this global problem. Public discourse on these drugs has focused on their off-label use by celebrities, their exorbitant pricing, and severe supply shortages. But these issues are distractions from difficult questions about the long term implications of using these drugs in holistic obesity care systems, for both individual patients and for public health—namely, for whom, for what purpose, and how should these drugs be used when taking a lifecourse view of care for people with obesity?

Obesity is a hugely complex issue.

An excellent editorial this month in the @bmj.com from @drjuanfranco.bsky.social and @iddocjen.bsky.social on how the new drugs now available aren’t necessarily a magic bullet.

Even if they are, lifelong support is needed for those affected.

#MedSky
#Obesity

18.01.2025 10:18 — 👍 18    🔁 7    💬 3    📌 4
Preview
Tabakentwöhnung durch Nikotin oder Vareniclin bei schwerer und leichter Tabakabhängigkeit Tabakrauchen gilt als das verbreitetste vermeidbare Gesundheitsrisiko in Deutschland. Zu den durch den Tabakkonsum beg�nstigten Erkrankungen geh�ren vor allem kardiovaskul�re Erkrankungen, chronisch o...

This brand new systematic review and meta-analysis shows that nicotine replacement therapy and varenicline are effective smoking cessation treatments - independent of the level of tobacco dependence! (the English version of the article will follow soon)

www.aerzteblatt.de/archiv/24240...

10.01.2025 10:40 — 👍 1    🔁 1    💬 0    📌 0
Preview
Physical activity and tobacco smoking in the German adult population Background Physical inactivity and tobacco smoking remain the leading causes of morbidity and mortality worldwide. In Germany, smoking prevalence is high at around 30%, and only 45% achieve the WHO re...

What is the association between physical activity 🏃 and smoking 🚬? Our new study shows that in 🇩🇪, physically active people are less likely to be a smoker. Smokers who are physically active smoke fewer cigarettes per day and have a higher motivation to stop smoking. bmjopensem.bmj.com/content/10/4...

06.01.2025 10:54 — 👍 1    🔁 3    💬 0    📌 0

@danielkotz.bsky.social @mintimetz.bsky.social

03.01.2025 09:58 — 👍 0    🔁 0    💬 0    📌 0
Preview
Juan VA Franco on LinkedIn: Call for applicants 🌟 Join Our Research Team! 🌟 Are you passionate about evidence-based research and systematic reviews? Our institute, including the Cochrane Evidence Synthesis…

🌟 Join Our Research Team! 🌟
Our institute, including the Cochrane Evidence Synthesis Unit, seeks talented researchers to join our dynamic team!
We are hiring systematic reviewers to work on high-priority topics that make a real-world impact. 🚀
Details:
www.linkedin.com/posts/juan-v...

03.01.2025 09:58 — 👍 1    🔁 1    💬 1    📌 0
Post image

Happy New Year! We are back with Helen and me for the #TalkEvidence Podcast, this time looking back at the Christmas issue: cognitive decline and AI, mittens for osteoarthritis and more!
Special Guest: @tfeend.bsky.social

🎧 Apple Podcasts: apple.co/41RzAam

🎧 Spotify: spoti.fi/4gETMRa

02.01.2025 14:08 — 👍 3    🔁 1    💬 0    📌 0
Feuerwerk über dem Oeconomicum

Feuerwerk über dem Oeconomicum

Wir wünschen allen einen guten Rutsch ins Jahr 2025! Kommt gut rein und bis bald auf dem Campus!
^dw

31.12.2024 08:29 — 👍 28    🔁 1    💬 0    📌 0

"We must remember our human obligation to care—there as well as here—in a world split between peace and violence, privilege and deprivation."

Don’t turn away from the suffering in the world, write Fares Alahdab and @vmontori.bsky.social
#ChristmasBMJ
www.bmj.com/content/387/...

16.12.2024 16:11 — 👍 25    🔁 14    💬 0    📌 2

Good idea!!!! 💪🏽

24.12.2024 19:33 — 👍 1    🔁 1    💬 0    📌 0
Post image Post image Post image

An investigation by The BMJ shows the extent of the fossil fuel industry’s involvement in medical research, leading to fresh calls for academics and publishing companies to cut ties with such companies
www.bmj.com/content/387/...

28.11.2024 10:30 — 👍 116    🔁 73    💬 1    📌 12

@drjuanfranco is following 14 prominent accounts